Important Notice for Baxter International Investors
Attention to all shareholders of Baxter International, Inc. (NYSE: BAX). If you’ve invested in Baxter shares and suffered losses, there’s an opportunity you won’t want to miss. The Gross Law Firm is reaching out to investors during this critical moment to inform them about a class action that could potentially lead to recovery.
What is the Class Period?
The class action pertains to shares purchased between February 23, 2022, and July 30, 2025. If you were among those who acquired shares during this time frame, The Gross Law Firm encourages you to consider contacting them for support regarding your options.
What Alleges the Complaint?
The allegations in the complaint highlight serious concerns regarding Baxter’s Novum LVP product, which has reportedly suffered from systemic issues leading to malfunctions. Such problems include underinfusion and complete non-delivery of fluids, putting patients at risk for significant adverse effects, including serious injury or even death. Furthermore, the company was allegedly aware of these defects and the ensuing injuries but failed to communicate effectively with its clients.
Details of the Allegations
Key points of the allegation state that:
- Baxter's Novum LVP was found to have defects that posed severe risks to patients.
- The company was informed of various malfunctions, with serious consequences stemming from these issues.
- Efforts to mitigate these concerns through customer alerts were deemed insufficient as the design flaws persisted.
These troubling issues have raised concerns about whether Baxter can maintain its sales and reputation moving forward.
Deadline for Action
Mark your calendars as the deadline for registering for this class action is December 15, 2025. It's crucial for shareholders to engage promptly to ensure they do not miss this opportunity.
Next Steps for Interested Shareholders
If you are a shareholder who acquired shares of BAX during the specified period, registering for this class action ensures you’ll be included in updates about the case. This means you’ll be informed of any significant developments and have the chance to join potential recovery efforts without any financial costs involved.
Why Choose The Gross Law Firm?
The Gross Law Firm is a nationally recognized entity specializing in class action law. Their dedication rests on safeguarding the rights of investors, particularly those affected by corporate deceits or misleading practices. Their firm is steadfast in ensuring responsible business conduct, working tirelessly to recover losses incurred by investors when they were misled.
Contact Information
For further inquiries and guidance, investors can reach out to:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
Frequently Asked Questions
What should I do if I purchased shares of BAX during the class period?
If you purchased shares of Baxter during the class period, contact The Gross Law Firm to discuss your options regarding the class action.
What are the allegations against Baxter International?
The allegations include claims of systemic defects in their Novum LVP product, which put patients at risk, and that Baxter failed to disclose critical safety information.
How can I stay updated on the class action status?
By registering with The Gross Law Firm, you will receive updates regarding the progress of the class action and other relevant information.
Is there any cost to participate in the class action?
No, there are no costs or obligations for you to participate in the class action.
What is the deadline to register for the class action?
The deadline to register is December 15, 2025, so it's important to act quickly.
